Loading clinical trials...
Loading clinical trials...
Hungarian Multicenter Non-Interventional Study of Continued Avastin (Bevacizumab) Plus Chemotherapy Until First Progression Following Induction Treatment With Chemotherapy Doublet Plus Avastin in First Line Treatment of Patients With Metastatic Colorectal Carcinoma
Conditions
Interventions
Bevacizumab
Chemotherapy
Locations
22
Hungary
Szent Margit Hospital
Budapest, Hungary
Semmelweis Egyetem Onkologiai Központ
Budapest, Hungary
Szent Imre Hospital
Budapest, Hungary
Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly
Budapest, Hungary
Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika
Budapest, Hungary
Fövárosi Önkormányzat uzsoki utcai Kórház
Budapest, Hungary
Start Date
January 13, 2015
Primary Completion Date
December 29, 2017
Completion Date
December 29, 2017
Last Updated
August 23, 2018
NCT04704661
NCT06696768
NCT05489211
NCT04657068
NCT06625775
NCT06607458
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions